Coya Therapeutics (COYA) Net Cash Flow Growth (3y) (2025 - 2026)
Coya Therapeutics (COYA) Net Cash Flow Growth (3y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | -50.33% |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn | 38.47% |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 32.17% |
| 10 | Coya Therapeutics | 97.82 Mn | 47.10 Mn | - | -27.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.85% |
| Dec 31, 2025 | 107.08% |
| Sep 30, 2025 | 11.46% |
| Jun 30, 2025 | -39.47% |
| Mar 31, 2025 | -11.07% |